DBV Technologies | Ventas



Sales Cambio Fecha
Acadia Pharmaceuticals USD 259.6M 9.2M 2024-12
Alnylam Pharmaceuticals USD 593.17M 92.25M 2024-12
Amarin USD 42.3M 25.19M 2024-09
BioMarin Pharmaceutical USD 747.31M 1.57M 2024-12
DBV Technologies USD 560K 512K 2024-12
Halozyme Therapeutics USD 298.01M 7.92M 2024-12
Incyte USD 1.18B 40.83M 2024-12
Insmed USD 104.44M 11.02M 2024-12
Ionis Pharmaceuticals USD 226.58M 92.76M 2024-12
Neurocrine Biosciences USD 627.7M 5.6M 2024-12
PTC Therapeutics USD 213.17M 16.39M 2024-12
Sarepta Therapeutics USD 658.41M 191.24M 2024-12
Ultragenyx Pharmaceutical USD 164.88M 25.38M 2024-12
United Therapeutics USD 735.9M 13M 2024-12



DBV Technologies Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2025.